News: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

101.48USD
28 Jan 2015
Change (% chg)

$-0.61 (-0.60%)
Prev Close
$102.09
Open
$102.50
Day's High
$102.93
Day's Low
$101.44
Volume
2,512,160
Avg. Vol
2,480,394
52-wk High
$109.49
52-wk Low
$86.09

Search Stocks
Select another date:

Fri, Jan 23 2015

Plaintiffs’ lawyers reject J&J claims of fraud in mesh lawsuits

NEW YORK - Lawyers for thousands of women suing Johnson & Johnson’s Ethicon Inc over transvaginal mesh devices are fighting back against the company’s claim that illegal phone solicitations may have resulted in baseless lawsuits.

Plaintiffs' lawyers reject J&J claims of fraud in mesh lawsuits

NEW YORK - Lawyers for thousands of women suing Johnson & Johnson's Ethicon Inc over transvaginal mesh devices are fighting back against the company's claim that illegal phone solicitations may have resulted in baseless lawsuits.

Plaintiffs' lawyers reject J&J claims of fraud in mesh lawsuits

NEW YORK, Jan 23 - Lawyers for thousands of women suing Johnson & Johnson's Ethicon Inc over transvaginal mesh devices are fighting back against the company's claim that illegal phone solicitations may have resulted in baseless lawsuits.

New sponsors ready to replace old say beleaguered FIFA

LONDON - FIFA have rejected suggestions that major sponsors were cutting their ties with the organization because it was a "toxic brand", saying on Friday that they were in advanced negotiations with new sponsors eager to replace the old.

J&J's $7.2 bln claim against Boston Scientific now with U.S. judge

NEW YORK, Jan 21 - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.

Johnson & Johnson's $7.2 billion claim against Boston Scientific now with U.S. judge

NEW YORK - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial – and ultimately ill-fated – bidding war for device maker Guidant.

J&J's $7.2 bln claim against Boston Scientific now with U.S. judge

NEW YORK, Jan 21 - For more than eight years, Johnson & Johnson has pursued billions of dollars in damages against Boston Scientific Corp after the latter won a controversial - and ultimately ill-fated - bidding war for device maker Guidant.

Stronger dollar hurts J&J's quarterly sales

- Johnson & Johnson reported lower-than-expected quarterly sales as a stronger dollar offset higher sales of the Band-Aid maker's new drugs and older treatments.

Johnson & Johnson's forex warning a sign for rival drugmakers

- Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck & Co .

Johnson & Johnson's forex warning a sign for rival drugmakers

Jan 20 - Johnson & Johnson surprised investors by detailing the degree to which a strong dollar will hurt sales abroad this year, and industry watchers say Wall Street is underestimating the likely hit to other U.S.-based rivals such as Pfizer Inc and Merck & Co.

Select another date:
Search Stocks